Open AccessReal-world outcomes of intravitreal antivascular endothelial growth factors for neovascular age-related macular degeneration in Taiwan: A 4-year longitudinal study
Author(s) -
Benjamin Chi-Lan Yang,
Terry Yu-Hung Chou,
SanNi Chen
Publication year - 2019
Publication title -
taiwan journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.519
H-Index - 9
eISSN - 2211-5072
pISSN - 2211-5056
DOI - 10.4103/tjo.tjo_34_19
Subject(s) - medicine , aflibercept , macular degeneration , visual acuity , ranibizumab , bevacizumab , ophthalmology , regimen , retrospective cohort study , pro re nata , surgery , chemotherapy
The purpose of the study is to report the long-term efficacy of patients with neovascular age-related macular degeneration (nAMD) treated with antivascular endothelial growth factor (VEGF) in Changhua Christian Hospital in Taiwan.